Form 8-K - Current report:
SEC Accession No. 0001193125-25-151306
Filing Date
2025-06-27
Accepted
2025-06-27 16:28:40
Documents
18
Period of Report
2025-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d928306d8k.htm   iXBRL 8-K 57894
2 EX-2.1 d928306dex21.htm EX-2.1 461740
3 EX-2.2 d928306dex22.htm EX-2.2 121073
4 EX-10.1 d928306dex101.htm EX-10.1 87963
5 EX-99.1 d928306dex991.htm EX-99.1 17824
9 GRAPHIC g928306g0626235151769.jpg GRAPHIC 3689
10 GRAPHIC g928306g0627042529382.jpg GRAPHIC 3780
  Complete submission text file 0001193125-25-151306.txt   1057352

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tsbx-20250626.xsd EX-101.SCH 2866
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsbx-20250626_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsbx-20250626_pre.xml EX-101.PRE 11718
21 EXTRACTED XBRL INSTANCE DOCUMENT d928306d8k_htm.xml XML 3798
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 251086769
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)